Related references
Note: Only part of the references are listed.Keratinocyte but Not Endothelial Cell-Specific Overexpression of Tie2 Leads to the Development of Psoriasis
Julie A. Wolfram et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia
Manuela Voinea Calin et al.
CELL AND TISSUE RESEARCH (2009)
Key Role of Macrophages in the Pathogenesis of CD18 Hypomorphic Murine Model of Psoriasis
Honglin Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Induction of IL-17+ T cell trafficking and development by IFN-γ:: Mechanism and pathological relevance in psoriasis
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2008)
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis
Andrew Blauvelt
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T-H-17 responses
Elisabetta Volpe et al.
NATURE IMMUNOLOGY (2008)
The cytokine and chemokine network in psoriasis
Brian J. Nickoloff et al.
CLINICS IN DERMATOLOGY (2007)
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis
Gerald G. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis
Eiko Toichi et al.
JOURNAL OF IMMUNOLOGY (2006)
Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation
Honglin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation
Athanasios Stratis et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis:: Gene regulation and cellular effects
Frank Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
MA Lowes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
R Zenz et al.
NATURE (2005)
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
CE Antoni et al.
ARTHRITIS AND RHEUMATISM (2005)
Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder
AG Li et al.
EMBO JOURNAL (2004)
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris
E Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
AB Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis
CL Kauffman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Etanercept treatment of psoriatic arthritis - Safety, efficacy, and effect on disease progression
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2004)
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis
CS Carlin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
A randomized trial of etanercept as monotherapy for psoriasis
AB Gottlieb et al.
ARCHIVES OF DERMATOLOGY (2003)
Etanercept as monotherapy in patients with psoriasis
CL Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
YP Xia et al.
BLOOD (2003)
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
M Pasparakis et al.
NATURE (2002)
Suppression of immunoreactive macrophages in atheromatous lesions of rabbits by clodronate
R Ylitalo et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function
N Jones et al.
EMBO REPORTS (2001)
Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter
I Diamond et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
